Aliquots Archives
DNA: From modification to mutation
Jun. 8, 2012—Understanding how an environmental hazard damages DNA may shed light on processes of tumor formation.
Long live the therapeutic stem cells
May. 17, 2012—Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.
New clue to ADHD
May. 15, 2012—A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.
Perfect timing for sensory processing
May. 11, 2012—Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.
Probing epilepsy’s molecular sparks
May. 10, 2012—Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.
Early stomach troubles augur anxiety
May. 2, 2012—Children with stomach troubles grow up to be anxious adolescents and young adults, according to a recent study.
Better blood pressure-reducing drugs?
Apr. 30, 2012—A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.
Dengue antibodies give vaccine leads
Apr. 27, 2012—New information may help speed development of a vaccine or treatment for dengue fever.
New drug mutes more melanomas
Apr. 26, 2012—An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
Neuronal clues to cholesterol-defect disorder
Apr. 20, 2012—Antioxidants may be a beneficial treatment for an inherited genetic disorder.
Pathways to delirium in the ICU
Apr. 17, 2012—Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.
Wilms’ tumors differ in developing nations
Apr. 13, 2012—In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations.
